#6100
Aspergillus
fumigatus IgG ELISA
ELISA kit for the diagnosis of human aspergillosis
Lot 2509A (Expiry date: 19.10.2026)
Production date : 20.02.2025
Results of quality control 1 (after
production), date: 25.02.2025
No serum blank (average) : 0.126
Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
-0.003 |
-0.001 |
-0.002 |
0.005 |
0.000 |
0 |
Negative control serum
(N° 6100-06) |
0.048 |
0.044 |
0.054 |
0.051 |
0.050 |
2 |
Weak positive serum
(N° 6100-07) |
0.544 |
0.517 |
0.567 |
0.493 |
0.531 |
25 |
Positive control
serum
(N° 6100-08) |
2.175 |
2.138 |
2.160 |
2.105 |
2.145 |
100 |
Validation criteria:
|
Criterion |
Measure |
Valid |
Absorbance of positive serum 6100-08 |
> 1.200 |
2.145 |
Yes |
Absorbance of weak positive serum 6100-07, as % of positive serum
|
> 11 % |
25 % |
Yes |
Absorbance of negative serum 6100-06, as % of positive serum |
< 8 % |
2 % |
Yes |
Absorbance of no serum blank |
< 0.350 |
0.126 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bātiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|